BioPharmSignal logoBioPharmSignal

Biotech News

Forian Inc. Announces $24 Million Private Placement of 3.5% Convertible Notes due 2025, Appoints New Chief Financial Officer

Forian (FORA)ForianFinancing

NEWTOWN, Pa., Sept. 1, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced the following:

<a...

Related news

FORAForian2021-04-12 17:54 EST

Forian Inc. Announces $12 Million Private Placement of Common Stock

FORAForian2025-08-25 13:06 EST

Forian Receives Unsolicited Proposal from CEO to be Taken Private

View all latest news

Forian

Forian is a healthcare data and analytics company focused on information services, software, and workflow tools. Its business is about using data infrastructure to support healthcare and life-sciences decisions.

Recent company news

FORAForian2025-10-30 17:36 EST

Forian Inc. to Announce Third Quarter 2025 Results on November 14, 2025

FORAForian2025-08-25 13:06 EST

Forian Receives Unsolicited Proposal from CEO to be Taken Private

FORAForian2025-05-06 16:33 EST

Forian Inc. to Announce First Quarter 2025 Results on May 14, 2025

FORAForian2024-12-16 08:00 EST

Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics

FORAForian2024-11-13 16:00 EST

Forian Inc. Announces Third Quarter 2024 Financial Results

Stock data

Close
2.17 USD
Market cap
67.79M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States